Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05483985 · ClinicalTrials.gov registry record · NA

Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for Transfer

A NA study of Infertility, sponsored by Alife Health.

Active
Registry status
NA
Development phase
440
Enrollment target
7
Study locations

NCT05483985 is a NA study of Infertility that is active but no longer recruiting, run by Alife Health. The registered enrollment target is 440 participants, below the 7,584-participant average among 74 other Infertility trials with a reported enrollment target (94% lower). The trial reports 7 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05483985, a NA study of Infertility, is active but no longer recruiting, sponsored by Alife Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
440 participants
Enrollment target
7
Study locations

Study Summary

To evaluate the clinical pregnancy rate (pregnancy defined as fetal heartbeat at 6-8 weeks) with the adjunctive use of the Hera System (Hera System used with traditional morphological grading) with embryos already deemed suitable for transfer compared to trained embryologists using standard morphology criteria alone.

Conditions Studied

Interventions

  • DEVICE Hera Score

Study Locations (7)

California

  • CCRM - Menlo Park
  • Reproductive Science Center - San Ramon

Florida

  • IVF Florida Reproductive Associates - Margate
  • Center for Reproductive Medicine - Winter Park

Texas

  • Ovation Fertility - Austin
  • Aspire Fertility - San Antonio

Utah

  • Reproductive Care Center - Sandy City

Trial Details

FieldValue
Enrollment Target 440 participants
Start Date 2022-06-13
Est. Completion 2025-01
Phase NA

Sponsor

Alife Health

1 total trials

What the Registry Record Tells You About NCT05483985

The ClinicalTrials.gov registry entry for NCT05483985 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 440 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,584-participant average among 74 other Infertility trials with a reported enrollment target (94% lower). The listed sponsor is Alife Health, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which Hera Score is the first listed.

NCT05483985 reports 7 study locations spanning 4 distinct geographic areas - top geographies include California, Florida, Texas.

Frequently Asked Questions

What is clinical trial NCT05483985 about?

NCT05483985 is a clinical study titled "Evaluation of the Alife Hera System as an Adjunctive Tool for the Prioritization of Embryos Deemed Suitable for Transfer". To evaluate the clinical pregnancy rate (pregnancy defined as fetal heartbeat at 6-8 weeks) with the adjunctive use of the Hera System (Hera System used with traditional morphological grading) with embryos already deemed suitable for transfer compared to trained embryologists using standard morpholo...

What is the current status of trial NCT05483985?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2022-06-13. Estimated completion is 2025-01.

What conditions does trial NCT05483985 study?

This clinical trial studies the following conditions: Infertility.

What interventions are being tested in trial NCT05483985?

The interventions under investigation include: Hera Score (DEVICE).

Who is sponsoring clinical trial NCT05483985?

This trial is sponsored by Alife Health, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05483985 being conducted?

This trial has 7 study locations across California, Florida, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.